These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli. de Cristóbal RE; Vincent PA; Salomón RA J Antimicrob Chemother; 2006 Jul; 58(1):31-6. PubMed ID: 16687460 [TBL] [Abstract][Full Text] [Related]
23. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli. Paltansing S; Tengeler AC; Kraakman ME; Claas EC; Bernards AT Microb Drug Resist; 2013 Dec; 19(6):469-76. PubMed ID: 23909485 [TBL] [Abstract][Full Text] [Related]
24. First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates. Cerquetti M; Giufrè M; Cardines R; Mastrantonio P Antimicrob Agents Chemother; 2007 Sep; 51(9):3155-61. PubMed ID: 17620383 [TBL] [Abstract][Full Text] [Related]
25. Drug-induced conformational changes in multidrug efflux transporter AcrB from Haemophilus influenzae. Dastidar V; Mao W; Lomovskaya O; Zgurskaya HI J Bacteriol; 2007 Aug; 189(15):5550-8. PubMed ID: 17526713 [TBL] [Abstract][Full Text] [Related]
26. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G). Preisler A; Heisig P J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246 [TBL] [Abstract][Full Text] [Related]
27. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. Zheng J; Cui S; Meng J J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645 [TBL] [Abstract][Full Text] [Related]
28. AcrA dependency of the AcrD efflux pump in Salmonella enterica serovar Typhimurium. Yamasaki S; Nagasawa S; Hayashi-Nishino M; Yamaguchi A; Nishino K J Antibiot (Tokyo); 2011 Jun; 64(6):433-7. PubMed ID: 21505470 [TBL] [Abstract][Full Text] [Related]
29. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698. Lofland D; Difuntorum S; Waller A; Clements JM; Weaver MK; Karlowsky JA; Johnson K J Antimicrob Chemother; 2004 Apr; 53(4):664-8. PubMed ID: 14973152 [TBL] [Abstract][Full Text] [Related]
30. Small RNA Regulation of TolC, the Outer Membrane Component of Bacterial Multidrug Transporters. Parker A; Gottesman S J Bacteriol; 2016 Jan; 198(7):1101-13. PubMed ID: 26811318 [TBL] [Abstract][Full Text] [Related]
31. The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates. Yang H; Duan G; Zhu J; Lv R; Xi Y; Zhang W; Fan Q; Zhang M Microb Drug Resist; 2008 Dec; 14(4):245-9. PubMed ID: 19035770 [TBL] [Abstract][Full Text] [Related]
32. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614 [TBL] [Abstract][Full Text] [Related]
33. Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase. Fritsche TR; Moet GJ; Jones RN Clin Microbiol Infect; 2004 Sep; 10(9):857-60. PubMed ID: 15355422 [TBL] [Abstract][Full Text] [Related]
34. Antibiotic-sensitive TolC mutants and their suppressors. Augustus AM; Celaya T; Husain F; Humbard M; Misra R J Bacteriol; 2004 Mar; 186(6):1851-60. PubMed ID: 14996816 [TBL] [Abstract][Full Text] [Related]
35. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. Zhong X; Xu H; Chen D; Zhou H; Hu X; Cheng G PLoS One; 2014; 9(12):e115185. PubMed ID: 25503276 [TBL] [Abstract][Full Text] [Related]
37. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. García-Cobos S; Campos J; Lázaro E; Román F; Cercenado E; García-Rey C; Pérez-Vázquez M; Oteo J; de Abajo F Antimicrob Agents Chemother; 2007 Jul; 51(7):2564-73. PubMed ID: 17470649 [TBL] [Abstract][Full Text] [Related]
38. AcrAB-TolC efflux pump overexpression and tet(A) gene mutation increase tigecycline resistance in Klebsiella pneumoniae. Xia Z; Zhou J; Gao N; Li G; Liu R; Lu G; Shen J World J Microbiol Biotechnol; 2024 Jun; 40(8):233. PubMed ID: 38842631 [TBL] [Abstract][Full Text] [Related]
39. Redundancy in the periplasmic adaptor proteins AcrA and AcrE provides resilience and an ability to export substrates of multidrug efflux. Smith HE; Blair JM J Antimicrob Chemother; 2014 Apr; 69(4):982-7. PubMed ID: 24302652 [TBL] [Abstract][Full Text] [Related]
40. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. Fralick JA J Bacteriol; 1996 Oct; 178(19):5803-5. PubMed ID: 8824631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]